Table 2.
Device | Specs (grams, flow, placement, levitation) | Unique Features |
Thoratec HeartMate II | 375, AX, IA | most widely studied > 200 publications |
Jarvik 2000 | 85, AX, IP | documented survival 7.5 years |
Micromed DeBakey 5 | 93, AX, IP | direct flow measurement |
Terumo Dura-Heart | 540, RA, IA, ML | hydrodynamic backup system |
HeartWare HVAD | 145, RA, IP, ML+ | uni/biventricular capabilities smallest design |
Berlin Heart Incor | 200, AX, IP, ML | only 3rd generation AX >500 implants |
Levacor VAD | 440, RA, IA, ML | complete magnetic suspension |
Thoratec HeartMate III | 500, RA, IA, ML | artificial pulse generator, sensorless flow estimator |
AX: axial flow; BTT: bridge to transplant; C: clinical; CE: European approved; DT: destination therapy; FDA: Food and Drug Administration; HDE: humanitarian device exemption; HF: heart failure; IA: intra-abdominal; IDE: investigational device exemption; IP: intrapericardial; ML: magnetically levitated; ML+: mixed ML with hydrodynamics; RA: radial flow.